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Abstract
During the peak phase of the COVID-19 pandemic, alterations of standard operating procedures were necessary for
health systems to protect patients and healthcare workers and ensure access to vital hospital resources. As the peak
phase passes, re-activation plans are required to safely manage increasing clinical volumes. In the context of
cardiovascular magnetic resonance (CMR), re-activation objectives include continued performance of urgent CMR
studies and resumption of CMR in patients with semi-urgent and elective indications in an environment that is safe
for both patients and health care workers.
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Introduction
The global pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the resultant
clinical syndrome COVID-19 [1, 2] has now spread to
188 countries with over 11.2 million infections and over
531,000 deaths around the world as of July 5, 2020 [3].
Throughout the evolution of the pandemic, most regions
have experienced a surge of cases which threatened to
overwhelm vital health system resources including
intensive care facilities, ventilators, and personal protect-
ive equipment (PPE) for frontline health care workers
[4]. In order to aid virus containment efforts, in the
United States, the Centers for Medicare and Medicaid
Services (CMS) recommended that non-essential med-
ical procedures be delayed during the peak-phase of the
pandemic [5]. Similarly, both the European Society of
Radiology (ESR) and European Society of Cardiac Radi-
ology (ESCR) explicitly recommended to post-pone non-
urgent procedures and restrict imaging services to those
indications having an immediate impact on patient’s
management, as the imaging procedure interrupts social
distancing and potentially exposes to infection [6, 7].
Most health systems have responded by significantly
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limiting non-urgent and elective medical care including
elective diagnostic imaging [8].
The Society for Cardiovascular Magnetic Resonance
(SCMR) has recently provided guidance on best prac-
tices for cardiovascular magnetic resonance (CMR)
utilization during the COVID-19 pandemic [9]. As the
first peak is passing in many locations around the world,
some local governments and health care systems have
been encouraged to slowly and safely transition to pre-
COVID-19 health care delivery volumes [10]. Further,
there is increasing recognition of CMR’s unique ability
to assess COVID-19-related cardiovascular complica-
tions in a single non-invasive examination. This next
phase requires further guidance on the safe and effective
practice of CMR highlighted by continued timely per-
formance of urgent CMR studies, including CMR in pa-
tients with COVID-19-related cardiac disease (Fig. 1),
while slowly increasing the number of CMR studies per-
formed in non-COVID patients with semi-urgent and
elective indications.
Purpose
In this context, the overarching goal of this document is
to provide a COVID-19 re-activation strategy specifically
for CMR practices with the goal of offering CMR ser-
vices in an environment which is as safe as possible for
patients, technologists, physicians, and other frontline
staff (Fig. 2).
When is CMR re-activation appropriate?
Many national and local governments continue to pro-
vide guidance and regulations related to physical distan-
cing protocols, stay-at-home and shelter-in-place orders,
PPE precautions, and other regulatory matters. More-
over, local healthcare systems and hospitals are provid-
ing updated guidelines for patients, staff, and physicians
who are transitioning back to more normalized health-
care delivery. The guidelines for CMR practice re-
activation provided in this document are intended only
as a supplement to these local governmental and health
system guidelines which should be adhered to at all
times.
When evaluating the appropriate timing to scale up
semi-urgent and elective procedures, CMR units should
consider coordinating with local and state public health
and hospital system officials to review the availability of
PPE for staff and patients, testing capacity, CMR facility
readiness including physical distancing preparedness in
reception areas, and workforce availability (including
technologists, nurses, and interpreting physicians).
Moreover, the needs of specific clinical services which
are also re-activating should also be considered includ-
ing other MRI specialties, electrophysiology, other im-
aging, interventional cardiology, heart failure, cardiac
surgery, thoracic surgery, and vascular surgery [11]. Re-
activation should proceed at a rate that appropriately
balances the availability of resources with the clinical de-
mand for CMR examinations and patient readiness.
Determining appropriate CMR indications during re-
activation
In the recent initial COVID-19 guideline document, the
SCMR classified cardiovascular imaging examinations as
urgent, semi-urgent, and elective, and advised that most
non-urgent exams be delayed [9]. As the first peak phase
passes, semi-urgent and elective CMR examinations can
begin to be scheduled. The American College of Radi-
ology (ACR) has provided guidance on the safe resump-
tion of non-urgent diagnostic imaging, while a
consensus document from multiple North American
cardiovascular societies has outlined procedures for safe
re-introduction of cardiovascular services [11, 12]. Ac-
cording to the ESCR, cardiac imaging programs should
be firstly reopened to patients with “subacute” indica-
tions that were rescheduled during the pandemic,
whereas pre-operative scans may be scheduled close to
the surgical procedures [7]. In general, identifying appro-
priate examinations and scheduling time frames should
be based on shared decision making between referring
providers, CMR unit physicians and staff, and patients.
While this approach is always recommended, the
Fig. 1 Example cardiovascular magnetic resonance (CMR) images of a patient with COVID-19 infection and acute myocarditis. Short axis cine of
the basal infero-lateral wall (a), corresponding T2-map (b) demonstrating elevation of T2 indicating presence of edema (black arrow) and phase
sensitive inversion recovery (PSIR) late gadolinium enhancement (LGE) (c) showing sub-epicardial enhancement (arrow)
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COVID-19 specific risks associated with imaging pa-
tients, including risks to frontline healthcare workers,
must be weighed against the benefit of the examination.
Thus, if a patient’s risk of illness or death from delaying
CMR is greater than the risk of nosocomial transmission
to healthcare workers and patients, then the CMR exam-
ination should be performed in a timely fashion.
A tiered plan for re-activation based on study indica-
tion and urgency will be useful for prioritizing patients
for scheduling purposes. However, in order to limit po-
tential exposures, other considerations should also influ-
ence scheduling of CMR examinations including
additional patient appointments at the same facility, the
potential impact of CMR findings on timing and avail-
ability of surgical procedures, and the availability of the
CMR unit team including technologists and nursing. Pa-
tients whose CMR procedures were delayed as a result
of the pandemic should also be prioritized as much as
possible, but it is reasonable to re-assess the appropriate-
ness of the exam and consider the availability or recent
performance of alternative diagnostic modalities given
the potentially long interval since the original imaging
order was placed.
Once a particular patient and indication is deemed ap-
propriate, the optimal CMR protocol must be carefully
considered to ensure successful diagnosis and minimize
the likelihood of patient callbacks or other delays in in-
terpretation. Generally, CMR studies should be tailored
to answer a particular clinical question(s) with the goal
of creating time-efficient protocols [13]. However, in the
context of COVID19, reducing redundancy in diagnostic
testing can help limit exposure, and opportunities to ex-
pand CMR protocols should be considered in a multidis-
ciplinary fashion. A representative example is the
resumption of electrophysiology ablation procedures
which require pulmonary vein mapping. If CMR pul-
monary vein mapping is performed, the CMR protocol
may be optimized to evaluate for left atrial appendage
(LAA) thrombus by including long inversion time late
gadolinium enhanced (LGE) images through the LAA,
or targeted, post-gadolinium balanced steady state free
precession (bSSFP) cine imaging [14, 15]. These modifi-
cations could reduce the need for dedicated transesoph-
ageal echocardiography for LAA thrombus evaluation
and be particularly useful at high volume institutions.
Other similar protocol modifications can be considered
and may include the addition of stress perfusion CMR,
dedicated valvular imaging, or CMR angiography as may
be appropriate in a given patient with the goal of de-
creasing potential overall patient and healthcare worker
COVID-19 exposure.
Additional strategies to consider include the imple-
mentation of rapid imaging protocols to reduce imaging
times and improve throughput. Both the Impact of Non-
invasive CMR Assessment (INCA) Peru study and the
Rapid Cardiovascular Magnetic Resonance for Ischemic
Heart Disease Investigation (RAPID-IHD) study have
demonstrated the feasibility of acquiring localizer im-
ages, short and long axis segmented bSSFP cine images,
and LGE with scan times averaging less than 20min [16,
17]. Additional sequences such as native T1 or T2 map-
ping could then be easily added to this protocol in ap-
propriately selected patients.
Patient and healthcare worker COVID-19 safety
precautions
Patient screening and COVID-19 status (Fig. 3)
Safety precautions which have been implemented during
the peak-phase of the pandemic must continue including
screening patients, healthcare workers, and, if allowed,
visitors or patient support guests for COVID-19 symp-
toms and exposure. Most health systems have devised
criteria based on current or recent symptoms and poten-
tial exposure history to help triage patients for further
laboratory testing. Ideally, all patients, and particularly
any patient with concerning symptoms or exposure his-
tory, as well as exposed healthcare workers should be
evaluated with a real-time polymerase chain reaction
Fig. 2 Key considerations for successful CMR COVID-19 re-activation. The CMR demand from referring services and the availability of resources
(scanners,personal protective equipment (PPE), staff) must be aligned. A multidisciplinary, risk-benefit approach is required to select patients,
indications, and protocols appropriately. The entire imaging pipeline including check-in, waiting, changing, and imaging must be safe and adhere
to guidelines related to screening, physical distancing, masks, and cleaning. Finally, in order to be effective, CMR must result in diagnostic images
with comprehensive interpretation
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(RT PCR) COVID-19 assay. However, local testing cri-
teria may change over time based on the availability of
tests and presumed local prevalence of disease. Pre-
imaging screening for symptoms of COVID-19 infection
or risk should be performed in all patients prior to
CMR, including patients with a history of negative
COVID-19 RT-PCR. This screening should ideally be
performed by phone 1–2 days prior to the imaging ap-
pointment and confirmed at the time of patient arrival.
Based on patient history, laboratory testing, and pre-
imaging screening, three subcategories of patients can be
defined: COVID-19 negative, COVID-19 positive (or
presumed positive/patient under investigation), and re-
covered COVID-19.
COVID-19 negative patients include those that have
no concerning symptoms or exposure history and may
or may not have tested negative for COVID-19. These
patients will generally present the lowest risk of trans-
mission to frontline healthcare workers and other pa-
tients. In general, with appropriate screening and PPE
precautions, these patients can resume CMR.
COVID-19 positive patients will generally be at higher
risk of transmitting the disease to healthcare workers
and other patients. This category should also include pa-
tients with COVID-19 symptoms or an exposure history
within the last 14 days, as well as any patients currently
being evaluated for COVID-19. This subgroup requires
careful consideration of the risks and benefits of the
CMR exam prior to performing images and, if possible,
exams should be delayed until the patient has recovered.
If delaying imaging would result in unacceptable delays
in patient care, imaging should be scheduled at a time
Fig. 3 Overview of CMR reactivation COVID-19 screening protocol
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which will limit exposure to other patients and health-
care workers. Strategies to reduce interactions, provide
adequate personal protective equipment, and sanitize the
imaging facility should be implemented as outlined
below.
The recovered COVID-19 patient subgroup is the
most challenging to define and may reflect an increasing
number of patients evaluated with CMR as the cardiac
complications associated with COVID-19 infection con-
tinue to manifest. Several strategies for defining recovery
have been suggested, including symptoms, time, or test-
based strategies. Recommendations from the United
States Centers for Disease Control and Prevention
(CDC) and World Health Organization (WHO) define
recovery as 1) 3 days since fever and respiratory symp-
toms have resolved, at least 10 days since first symptoms
appears, and if available, two consecutive negative RT-
PCR assays collected at least 24 h apart [18, 19]. If a pa-
tient never had symptoms but had a positive RT-PCR
assay, at least 10 days are required between the first posi-
tive test and consecutive negative tests. Local health sys-
tems may develop their own strategies for defining
recovery, and it currently is not clear how COVID-19
antibody testing may be used to better characterize this
group. The understanding of infectivity, viral load, and
immunity of recovered patients is evolving, although the
risk of spreading the virus in patients without active
symptoms is believed to be low [20, 21]. It is likely ap-
propriate to proceed with CMR for recovered patients in
most circumstances. However, it remains necessary to
adhere to all recommended physical distancing and PPE
guidelines, and to confirm that the patient has met re-
covery criteria and is currently asymptomatic prior to ar-
rival at the CMR center.
Physical distancing
In accordance with guidelines from the CDC [22], phys-
ical distancing is necessary to reduce the spread of the
virus and all waiting, check-in, and changing areas
should be arranged to allow appropriate space between
patients. In COVID-19 positive patients, isolated waiting
and changing areas are necessary. For all patients, alter-
native waiting strategies could also be considered includ-
ing waiting in cars while electronically checking in
rather than in-person at facility waiting areas. COVID-
19 screening and CMR safety screening should be per-
formed over the phone prior to patient arrival to further
reduce on-site time and unnecessary staff exposure to
symptomatic patients.
Imaging schedules should be arranged to minimize pa-
tient overlap in waiting areas (e.g. staggered procedure
start times), and to allow ample time for equipment
cleaning between exams. These precautions will likely
result in increased scan interval times and reductions in
overall patient volume. Facility specific solutions includ-
ing longer imaging hours could be considered as re-
quired by CMR demand, staff availability, and patient
acceptance.
As much as is feasible, reducing unnecessary contact
between individuals (patient-to-patient and patient-to-
healthcare worker) during the imaging appointment
should also be pursued. This may include additional
workflow changes such as one-way walkways, and en-
hanced communication between imaging staff, transport
teams, and others.
Personal protective equipment
Local guidelines for PPE should be followed including
the gowns, gloves, masks, and face shields. Availability of
appropriate PPE for frontline staff should be confirmed
prior to increasing CMR volumes and the local stock of
PPE should be regularly monitored.
Surgical masks for patients and healthcare workers
should be utilized as much as possible [22]. Many health
systems have mask requirements in place, but local guid-
ance on mask type and who must be masked should be
followed. The time-varying radiofrequency pulses and
magnetic field gradients used in CMR are hazardous for
patients with masks which contain small staples or me-
tallic components [23] and the metal component should
be removed prior to entry into the scan room. The ACR
has specific recommendations related to the use of
masks in MRI zone IV for patients and healthcare
personnel [24]. In general, patients should be fit with
MR-safe masks when available. If not available, standard
surgical masks could have metal components removed,
for example the nose bridge component, and the mask
can then be secured with tape. If patients bring non-
standard masks, part of the CMR safety check should in-
volve assessing mask components and transitioning to
CMR center provided masks. Patients should also be
instructed to alert the technologist to burning or pain
associated with the mask during the exam which may in-
dicate heating or displacement of ferromagnetic
components.
Since technologists and other healthcare workers will
not be in zone IV during scanning, the main mask-
related risk is magnetic forces on ferromagnetic compo-
nents of the mask when entering or leaving the scanner
room. Powered air-purifying respirators (PAPR) should
not be brought into the scanner room as they may con-
tain ferromagnetic components which can be damaged
by the magnetic field.
Cleaning and sanitization
Scanners, waiting areas, and changing areas should all be
cleaned in accordance with local agency guidelines and
hospital system requirements [22]. Realistic cleaning
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times should be confirmed prior to re-activation to avoid
unnecessary waiting and increased unnecessary patient-
patient and patient-healthcare work contact.
CMR in COVID-19 patients or persons under investigation
Cardiovascular complications of COVID-19 are increas-
ingly reported and there will likely be an increasing role
for CMR to better characterize these findings. Please
refer to the initial SCMR COVID-19 guidelines and on-
line Preparedness Toolkit for a complete description of
CMR imaging of COVID-19 patients or patients under
investigation for COVID-19, including ventilated pa-
tients [9, 25].
CMR image interpretation
Remote CMR image interpretation should provide the
highest level of protection to CMR interpreting physi-
cians. When this is not feasible, limiting the number of
staff on site is recommended. When on site, physical dis-
tancing measures are necessary including isolated read-
ing rooms and phone or text interactions with
technologists, nurses, and other physicians is preferred.
While urgent studies may require some compromise
in ideal image interpretation protocols, semi-urgent and
elective imaging should only be pursued when a compre-
hensive interpretation is feasible. The interpreting phys-
ician should have access to necessary high-resolution
screen, post-processing, 3D visualization, and cardiac
functional analysis and tissue characterization software.
In patients with findings which are suspicious for
COVID-19 infection including typical lung parenchymal
findings [26], myocarditis [27], or pulmonary embolism
[26], the ordering physician should immediately be made
aware. Notification is especially important in patients
who have not been diagnosed as COVID-19 positive and
are likely at increased risk of spreading the disease. For
cardiologist readers, suspicious extra-cardiac findings
should be discussed with a cardiothoracic radiologist.
Trainee education
For CMR units in academic settings, re-integrating
trainees into the scanner and reading room may be ap-
propriate during re-activation. This process should, how-
ever, adhere to local trainee-specific COVID-19
guidelines and should never compromise trainee safety.
Similar to interpreting physicians, trainees should work
remotely as much as feasible with teaching performed
remotely (e.g. phone or secure video conferencing).
When on site, trainees should adhere to all physical dis-
tancing and PPE guidelines. The number of trainees
working in a given unit should be proportional to the
volume of work such that the education experience is
valuable relative to the potential risks related to
infection.
CMR research
The resumption of CMR research should likely be per-
formed using a phased approach with the overall goal
for the safe and effective return to in-person research ac-
tivities while adhering to local and institutional guide-
lines. The strategies in many cases should mirror those
described above for clinical re-activation including com-
prehensive screening of research participants and staff,
appropriate physical distancing practices and PPE
utilization. Limiting the number of research staff in a
specific area, such as a CMR reading room, control
rooms, research offices, or laboratories at any given time
is also recommended. In general, research activities
should continue to be performed remotely as much as
possible with in-person activities performed only as
needed, making sure that equipment-cleaning measures
have been defined, and the number of individuals in-
volved in a given research visit minimized. Potential
phases for return to research activities may include the
initial resumption of phantom testing activities or pre-
clinical animal research while adequate screening, phys-
ical distancing, and PPE protocols are being developed.
Resuming human subjects research should likely focus
initially on time-sensitive research studies such as clin-
ical trials with pre-specified protocols, followed by less
restrictive human subject research. Obviously, the risk of
COVID-19 infection to subjects and staff should be con-
sidered when recruiting research subjects, and ideally
subjects would undergo COVID-19 testing prior to im-
aging whenever possible. Subjects should be made aware
of the safety protocols utilized by the research facility.
Also, research team members should receive specific
training on COVID-19 safety procedures.
Conclusion
As the SARS-CoV-2 pandemic transitions out of the
peak phase in most countries, it is appropriate for CMR
units to begin performing many semi-urgent and elective
CMR studies. Adherence to updated local institutional
guidelines, while balancing the benefits of imaging with
COVID-19 related risks to patients and healthcare
workers should guide re-activation timing and patient
selection.
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